Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Featured News
March 16, 2016
Cardiovascular
March 16, 2016
Arizona
March 15, 2016
Cancer
March 10, 2016
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community